US CDC panel endorses Pfizer booster shot for elderly, high-risk people

Xinhua | Updated: 2021-09-24 09:13

A patient receives the Pfizer-BioNTech coronavirus (COVID-19) vaccine during an Oakland County Health Department vaccination clinic at the Southfield Pavilion on Aug 24, 2021 in Southfield, Michigan. [Photo/Agencies]

WASHINGTON - A US Centers for Disease Control and Prevention (CDC) advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions.

The panel voted 15-0 to recommend a booster dose for Americans age 65 and older and people in long term care facilities. It also fully recommended giving a single booster dose to people between the ages of 50 and 64 with certain high risk conditions, by a vote of 13-2.

On Wednesday, the Food and Drug Administration approved Pfizer boosters for people aged 65 and older or at high-risk. The extra dose would be given once they are at least six months past their last Pfizer shot.

CDC Director Rochelle Walensky is expected to accept the panel's endorsement shortly.

Photo

Development of China-US ties tempered by hope, pragmatism

Highlights of China's 5th national economic census

Syrian armed groups agree on dissolution

New York Philharmonic to honor Chinese philanthropist

Pleas for aid and peace resonate for Gazans

A look at China's economic data in November